SB2385Introduced in the Senate
PATIENT ACCESS 340B PHARMACY
Introduced by David Koehler, District 46
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Creates the Patient Access to Pharmacy Protection Act. Defines terms. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless such receipt is prohibited by federal law. Provides that no person, including a pharmaceutical manufacturer, may impose any restriction on the ability of a 340B covered entity to contract with or designate a 340B contract pharmacy including restrictions relating to the number, location, ownership, or type of 340B contract pharmacy. Provides that no person, including a pharmaceutical manufacturer, may require or compel a 340B covered entity or 340B contract pharmacy to submit or otherwise provide ingredient cost or pricing data pertinent to 340B drugs unless required by State or federal law; institute requirements in any way relating to how a 340B covered entity manages its inventory of 340B drugs that are not required by a State or federal agency, including requirements relating to the frequency or scope of audits of inventory management systems of a 340B covered entity or a 340B contract pharmacy; or submit data or information that is not required by State or federal law as a condition for a 340B covered entity, its 340B contract pharmacy, or a location otherwise authorized by a 340B covered entity to receive 340B drugs. Sets forth provisions concerning enforcement of this Act; preemption of this Act; and severability of this Act. Effective immediately.
Where it stands
Rule 3-9(a) / Re-referred to Assignments
June 2, 2025
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Filed with Secretary by Sen. David Koehler
First Reading
Referred to Assignments
Added as Co-Sponsor Sen. Michael W. Halpin
Added as Co-Sponsor Sen. Javier L. Cervantes
Added as Co-Sponsor Sen. Graciela Guzmán
Added as Co-Sponsor Sen. Napoleon Harris III
Added as Co-Sponsor Sen. Mike Porfirio
Added as Co-Sponsor Sen. Paul Faraci
Added as Co-Sponsor Sen. Celina Villanueva
Added as Co-Sponsor Sen. Patrick J. Joyce
Added as Co-Sponsor Sen. Lakesia Collins
Added as Co-Sponsor Sen. Mary Edly-Allen
Added as Co-Sponsor Sen. Kimberly A. Lightford
Added as Co-Sponsor Sen. Rachel Ventura
Added as Co-Sponsor Sen. Mike Simmons
Added as Co-Sponsor Sen. Robert F. Martwick
Added as Co-Sponsor Sen. Steve Stadelman
Added as Chief Co-Sponsor Sen. Mattie Hunter
Assigned to Executive
Rule 2-10 Committee Deadline Established As April 4, 2025
Added as Co-Sponsor Sen. Jil Tracy
Added as Co-Sponsor Sen. Terri Bryant
Added as Chief Co-Sponsor Sen. Dale Fowler
Added as Co-Sponsor Sen. Ram Villivalam
Rule 2-10 Committee Deadline Established As April 11, 2025
Added as Co-Sponsor Sen. Laura M. Murphy
Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
Added as Co-Sponsor Sen. Sara Feigenholtz
Added as Co-Sponsor Sen. Robert Peters
Added as Co-Sponsor Sen. Sue Rezin
Added as Co-Sponsor Sen. Sally J. Turner
Rule 2-10 Committee/3rd Reading Deadline Established As May 23, 2025
Added as Chief Co-Sponsor Sen. Willie Preston
Senate Committee Amendment No. 1 Filed with Secretary by Sen. David Koehler
Senate Committee Amendment No. 1 Referred to Assignments
Rule 2-10 Committee/3rd Reading Deadline Established As June 1, 2025
Senate Committee Amendment No. 1 Pursuant to Senate Rule 3-8(b-1), the following amendments will remain in the Committee on Assignments
Rule 3-9(a) / Re-referred to Assignments
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.